Wells Fargo’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-24,987
| Closed | -$5K | – | 6334 |
|
|
2018
Q1 | $5K | Buy |
24,987
+4,858
| +24% | +$972 | ﹤0.01% | 5668 |
|
|
2017
Q4 | $26K | Sell |
20,129
-11,050
| -35% | -$14.3K | ﹤0.01% | 5397 |
|
|
2017
Q3 | $66K | Sell |
31,179
-14,459
| -32% | -$30.6K | ﹤0.01% | 5128 |
|
|
2017
Q2 | $132K | Buy |
45,638
+1,100
| +2% | +$3.18K | ﹤0.01% | 4841 |
|
|
2017
Q1 | $153K | Buy |
44,538
+20,988
| +89% | +$72.1K | ﹤0.01% | 4777 |
|
|
2016
Q4 | $41K | Buy |
23,550
+8,620
| +58% | +$15K | ﹤0.01% | 5161 |
|
|
2016
Q3 | $49K | Buy |
14,930
+8,945
| +149% | +$29.4K | ﹤0.01% | 5057 |
|
|
2016
Q2 | $26K | Sell |
5,985
-4,089
| -41% | -$17.8K | ﹤0.01% | 5180 |
|
|
2016
Q1 | $57K | Buy |
10,074
+227
| +2% | +$1.28K | ﹤0.01% | 4985 |
|
|
2015
Q4 | $170K | Sell |
9,847
-31,480
| -76% | -$543K | ﹤0.01% | 4401 |
|
|
2015
Q3 | $872K | Sell |
41,327
-33
| -0.1% | -$696 | ﹤0.01% | 3500 |
|
|
2015
Q2 | $2.05M | Buy |
41,360
+38,056
| +1,152% | +$1.88M | ﹤0.01% | 3056 |
|
|
2015
Q1 | $258K | Sell |
3,304
-21,785
| -87% | -$1.7M | ﹤0.01% | 4178 |
|
|
2014
Q4 | $1.52M | Buy |
25,089
+18,531
| +283% | +$1.12M | ﹤0.01% | 3178 |
|
|
2014
Q3 | $279K | Buy |
6,558
+764
| +13% | +$32.5K | ﹤0.01% | 4134 |
|
|
2014
Q2 | $358K | Buy |
5,794
+1,599
| +38% | +$98.8K | ﹤0.01% | 4022 |
|
|
2014
Q1 | $273K | Buy |
4,195
+565
| +16% | +$36.8K | ﹤0.01% | 4126 |
|
|
2013
Q4 | $205K | Sell |
3,630
-1,356
| -27% | -$76.6K | ﹤0.01% | 4177 |
|
|
2013
Q3 | $306K | Sell |
4,986
-30,117
| -86% | -$1.85M | ﹤0.01% | 3962 |
|
|
2013
Q2 | $2.05M | Buy |
+35,103
| New | +$2.05M | ﹤0.01% | 2790 |
|